Počet záznamov: 1
Neurobiology of cancer: the role of β-adrenergic receptor signaling in various tumor environments
Názov Neurobiology of cancer: the role of β-adrenergic receptor signaling in various tumor environments Autor Mravec Boris 1975 SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV SCOPUS RID ORCID Spoluautori Horváthová Ľubica 1983 SAVEXEND ; SAVBIOMED - Ústav experimentálnej endokrinológie SAV Hunáková Ľuba 1967- ORCID Zdroj.dok. International Journal of Molecular Sciences. Vol. 21, no. 21 (2020), art. no. 7958 Jazyk dok. eng - angličtina Poznámky open access URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy WEI, X. - CHEN, L. - YANG, A.M. - LV, Z.Y. - XIONG, M. - SHAN, C.X. ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironment. In TRANSLATIONAL CANCER RESEARCH. ISSN 2218-676X, DEC 2021, vol. 10, no. 12, p. 5280-+. Dostupné na: https://doi.org/10.21037/tcr-21-1257. CANU, L. - PUGLISI, S. - BERCHIALLA, P. - DE FILPO, G. - BRIGNARDELLO, F. - SCHIAVI, F. - FERRARA, A.M. - ZOVATO, S. - LUCONI, M. - PIA, A. - APPETECCHIA, M. - ARVAT, E. - LETIZIA, C. - MACCARIO, M. - PARASILITI-CAPRINO, M. - ALTIERI, B. - FAGGIANO, A. - MODICA, R. - MORELLI, V. - AROSIO, M. - VERGA, U. - PELLEGRINO, M. - PETRAMALA, L. - CONCISTRE, A. - RAZZORE, P. - ERCOLINO, T. - RAPIZZI, E. - MAGGI, M. - STIGLIANO, A. - BURRELLO, J. - TERZOLO, M. - OPOCHER, G. - MANNELLI, M. - REIMONDO, G. A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy. In CANCERS. NOV 2021, vol. 13, no. 22. Dostupné na: https://doi.org/10.3390/cancers13225831. ARCHER, M. - DOGRA, N. - DOVEY, Z. - GANTA, T. - JANG, H.S. - KHUSID, J.A. - LANTZ, A. - MIHALOPOULOS, M. - STOCKERT, J.A. - ZAHALKA, A. - BJORNEBO, L. - GAGLANI, S. - NOH, M.R. - KAPLAN, S.A. - MEHRAZIN, R. - BADANI, K.K. - WIKLUND, P. - TSAO, K. - LUNDON, D.J. - MOHAMED, N. - LUCIEN, F. - PADANILAM, B. - GUPTA, M. - TEWARI, A.K. - KYPRIANOU, N. Role of alpha- and beta-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease. In CELL COMMUNICATION AND SIGNALING. JUL 20 2021, vol. 19, no. 1. Dostupné na: https://doi.org/10.1186/s12964-021-00755-6. CARLOS-ESCALANTE, J.A. - DE JESUS-SANCHEZ, M. - RIVAS-CASTRO, A. - PICHARDO-ROJAS, P.S. - ARCE, C. - WEGMAN-OSTROSKY, T. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, MAY 20 2021, vol. 11. Dostupné na: https://doi.org/10.3389/fonc.2021.660943. YIP, H.Y.K. - PAPA, A. Signaling Pathways in Cancer: Therapeutic Targets, Combinatorial Treatments, and New Developments. In CELLS. MAR 2021, vol. 10, no. 3. Dostupné na: https://doi.org/10.3390/cells10030659. JENSEN, A.W.P. - SIMOES, A.M.C. - STRATEN, P.T. - OLOFSSON, G.H. Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?. In CANCERS. FEB 2021, vol. 13, no. 3. Dostupné na: https://doi.org/10.3390/cancers13030394. PRIYANKA, H.P. - NAIR, R.S. - KUMARAGURU, S. - SARAVANARAJ, K. - RAMASAMY, V. Insights on neuroendocrine regulation of immune mediators in female reproductive aging and cancer. In AIMS MOLECULAR SCIENCE. ISSN 2372-0301, 2021, vol. 8, no. 2, p. 127-148. Dostupné na: https://doi.org/10.3934/molsci.2021010. KOPP, W. Pathogenesis of (smoking-related) non-communicable diseases-Evidence for a common underlying pathophysiological pattern. In FRONTIERS IN PHYSIOLOGY. DEC 15 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fphys.2022.1037750. XU, Y.P. - LI, J.H. - LUO, Y. - MA, J.H. - HUANG, P. - CHEN, Y. - HE, Z.X. Carvedilol exhibits anti-acute T lymphoblastic leukemia effecti in/ii vitro/i andi in/ii vivo/i via inhibiting fl-ARs signaling pathway. In BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. ISSN 0006-291X, JAN 8 2023, vol. 639, p. 150-160. Dostupné na: https://doi.org/10.1016/j.bbrc.2022.11.093. YAN, X.B. - LIU, P.P. - LI, D.L. - HU, R. - TAO, M.Y. - ZHU, S.Y. - WU, W.J. - YANG, M.X. - QU, X. Novel evidence for the prognostic impact of β-blockers in solid cancer patients receiving immune checkpoint inhibitors. In INTERNATIONAL IMMUNOPHARMACOLOGY. ISSN 1567-5769, DEC 2022, vol. 113, A. Dostupné na: https://doi.org/10.1016/j.intimp.2022.109383. LIU, Y.X. - TIAN, S. - NING, B. - HUANG, T.H. - LI, Y. - WEI, Y.C. Stress and cancer: The mechanisms of immune dysregulation and management. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, OCT 5 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fimmu.2022.1032294. ZHANG, Y. - SONG, M.Y. - CHAN, A.T. - MEYERHARDT, J.A. - WILLETT, W.C. - GIOVANNUCCI, E.L. Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study. In BRITISH JOURNAL OF CANCER. ISSN 0007-0920, NOV 23 2022, vol. 127, no. 11, p. 1974-1982. Dostupné na: https://doi.org/10.1038/s41416-022-01975-4. SHI, J.Y. - XU, J. - LI, Y. - LI, B.W. - MING, H. - NICE, E.C. - HUANG, C.H. - LI, Q.F. - WANG, C. Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche. In FRONTIERS IN PHARMACOLOGY. AUG 29 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fphar.2022.990665. UDUMYAN, R. - BOTTERI, E. - JERLSTROM, T. - MONTGOMERY, S. - SMEDBY, K.E. - FALL, K. Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study. In ACTA ONCOLOGICA. ISSN 0284-186X, AUG 3 2022, vol. 61, no. 8, p. 922-930. Dostupné na: https://doi.org/10.1080/0284186X.2022.2101902. HERNANDEZ, S. - SERRANO, A.G. - SOTO, L.M.S. The Role of Nerve Fibers in the Tumor Immune Microenvironment of Solid Tumors. In ADVANCED BIOLOGY. ISSN 2701-0198, SEP 2022, vol. 6, no. 9, SI. Dostupné na: https://doi.org/10.1002/adbi.202200046. CHANG, H. - LEE, S.H. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis. In CLINICAL AND EXPERIMENTAL MEDICINE. ISSN 1591-8890, JUL 2023, vol. 23, no. 3, p. 853-858. Dostupné na: https://doi.org/10.1007/s10238-022-00842-z. LOURENçO, C. - CONCEIçAO, F. - JERóNIMO, C. - LAMGHARI, M. - SOUSA, D.M. Stress in Metastatic Breast Cancer: To the Bone and Beyond. In CANCERS. APR 2022, vol. 14, no. 8. Dostupné na: https://doi.org/10.3390/cancers14081881. LI, X.Y. - PENG, X.Q. - YANG, S. - WEI, S.B. - FAN, Q. - LIU, J.G. - YANG, L. - LI, H.Y. Targeting tumor innervation: premises, promises, and challenges. In CELL DEATH DISCOVERY. MAR 25 2022, vol. 8, no. 1. Dostupné na: https://doi.org/10.1038/s41420-022-00930-9. SILVA, D. - QUINTAS, C. - GONçALVES, J. - FRESCO, P. Contribution of adrenergic mechanisms for the stress-induced breast cancer carcinogenesis. In JOURNAL OF CELLULAR PHYSIOLOGY. ISSN 0021-9541, APR 2022, vol. 237, no. 4, p. 2107-2127. Dostupné na: https://doi.org/10.1002/jcp.30707. GRELET, S. - FRéREUX, C. - OBELLIANNE, C. - NOGUCHI, K. - HOWLEY, B.V. - DALTON, A.C. - HOWE, P.H. TGFβ-induced expression of long noncoding lincRNA Platr18 controls breast cancer axonogenesis. In LIFE SCIENCE ALLIANCE. FEB 2022, vol. 5, no. 2. Dostupné na: https://doi.org/10.26508/lsa.202101261. FJAESTAD, K.Y. - ROMER, A.M.A. - GOITEA, V. - JOHANSEN, A.Z. - THORSETH, M.L. - CARRETTA, M. - ENGELHOLM, L.H. - GRONTVED, L. - JUNKER, N. - MADSEN, D.H. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. In ONCOGENE. ISSN 0950-9232, FEB 25 2022, vol. 41, no. 9, p. 1364-1375. Dostupné na: https://doi.org/10.1038/s41388-021-02170-0. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2020 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.3390/ijms21217958 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Neurobiology of Cancer The Role of beta-Adrenergic receptor.pdf Prístupný 2.5 MB 2 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2020 2019 4.556 Q1 1.317 Q1
Počet záznamov: 1